Compound ID | 1832
Synonym(s): DDS-03 series
Class: null
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Targets electron transfer proteins (ETFs) A/B/D; electron transport chain inhibitor |
| Target Pathogen: | Active against Neisseria gonorrhoeae |
| Description: | Selective activity against Neisseria spp. Very low MIC values |
| Institute where first reported: | Summit Therapeutics |
| Year first mentioned: | 2018 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566547/ |